FDA weighs in on nitrosamines in drugs

被引：0

作者：

Erickson, Britt

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2020年 / 98卷 / 34期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：15 / 15

页数：1

相关论文

共 50 条

[41] FDA backs off malaria drugs
Brainard, Jeffrey
SCIENCE, 2020, 368 (6497) : 1292 - 1292
[42] FDA cGMP Requirements for PET Drugs
Norenberg, Jeffrey P.
Schwarz, Sally
VanBrocklin, Henry
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (05) : 16N - 16N
[43] FDA approval of HIV AIDS drugs
Gorbach, SL
Bartlett, JG
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (03) : 143 - 143
[44] FDA plans to fight fake drugs
不详
CHEMICAL & ENGINEERING NEWS, 2003, 81 (41) : 49 - 49
[45] FDA lowers the bar for biodefense drugs
Alan Dove
Nature Medicine, 2002, 8 : 646 - 646
[46] FDA PETITIONED OVER DRUGS IN WATER
不详
CHEMICAL & ENGINEERING NEWS, 2010, 88 (29) : 27 - 27
[47] FDA labeling system for drugs in pregnancy
Boothby, LA
Doering, PL
ANNALS OF PHARMACOTHERAPY, 2001, 35 (11) : 1485 - 1489
[48] FDA designates first rupture drugs
不详
BIOFUTUR, 2013, (341) : 16 - 16
[49] SYNTHETIC BIOMACROMOLECULAR DRUGS - AN FDA VIEWPOINT
EGAN, W
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 26 - BTEC
[50] FDA TO EASE REGULATION OF BIOTECH DRUGS
BARNETT, AA
LANCET, 1995, 346 (8986) : 1357 - 1357

← 1 2 3 4 5 →